Affiliation:
1. V.A. Nasonova Research Institute of Rheumatology
Abstract
The aim – to study risk factors for severe COVID-19 in patients with rheumatic diseases (RD).Patients and methods. The study included medical histories of 464 patients with RD who were admitted at the V.A. Nasonova Research Institute of Rheumatology from September 27, 2021 to April 26, 2023Results. Age over 60 years, hypertension, obesity, lung disease, chronic kidney disease, coronary heart disease, diabetes mellitus, acute cerebrovascular accident or a history of pulmonary tuberculosis increase the risk of hospitalization in patients with RD with COVID-19 by 3–5 times. In addition, with an increase in the number of concomitant diseases, an increase in the risk of hospitalization was noted by 2–6 times. Taking glucocorticoids, including at a dose of ≥10 mg per day for prednisolone, mycophenolate mofetil and rituximab, leads to an increase risk of hospitalization by 1.5–4.5 times, while patients taking hydroxychloroquine or tumor necrosis factor α inhibitors was more often required outpatient treatment.Conclusions. It has been established that older age, the presence of comorbid pathology and the use of glucocorticoids, including at a dose of ≥10 mg per day for prednisolone, mycophenolate mofetil and rituximab, are risk factors for severe COVID-19.
Reference35 articles.
1. The top 10 causes of death. URL: https://www.who.int/newsroom/fact-sheets/detail/the-top-10-causes-of-death (Accessed: 12th December 2023).
2. WHO Director-General’s opening remarks at the media briefing – 5 May 2023. URL: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarksat-the-media-briefing---5-may-2023 (Accessed: 12th December 2023).
3. Chandel A, Leazer S, Alcover KC, Farley J, Berk J, Jayne C, et al. Intensive care and organ support related mortality in patients with COVID-19: A systematic review and meta-analysis. Crit Care Explor. 2023;5(3):e0876. doi: 10.1097/CCE.0000000000000876
4. Glybochko PV, Fomin VV, Moiseev SV, Avdeev SN, Yavorsky AG, Brovko MYu, et al. Clinical outcomes of patients with COVID-19 admitted for respiratory support to the intensive care units in Russia. Clinical Pharmacology and Therapy. 2020;29(3):25-36 (In Russ.) doi: 10.32756/0869-5490- 2020-3-25-36
5. Chen Z, Peng Y, Wu X, Pang B, Yang F, Zheng W, et al. Comorbidities and complications of COVID-19 associated with diseaseseverity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis.Front Public Health. 2022;10:923485. doi: 10.3389/fpubh.2022.923485
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献